SE7910371L - Oralt intagbart lekemedel med inflammationshemmande verkan - Google Patents
Oralt intagbart lekemedel med inflammationshemmande verkanInfo
- Publication number
- SE7910371L SE7910371L SE7910371A SE7910371A SE7910371L SE 7910371 L SE7910371 L SE 7910371L SE 7910371 A SE7910371 A SE 7910371A SE 7910371 A SE7910371 A SE 7910371A SE 7910371 L SE7910371 L SE 7910371L
- Authority
- SE
- Sweden
- Prior art keywords
- inflammation
- medicine
- disability
- oral administrative
- effect
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2856333A DE2856333C2 (de) | 1978-12-27 | 1978-12-27 | Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7910371L true SE7910371L (sv) | 1980-06-28 |
SE448603B SE448603B (sv) | 1987-03-09 |
Family
ID=6058494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7910371A SE448603B (sv) | 1978-12-27 | 1979-12-17 | Oralt intagbart lekemedel innehallande en icke-steroid inflammationshemmande verksam bestandsdel och en eller flera fosfolipider |
Country Status (13)
Country | Link |
---|---|
US (1) | US4332795A (sv) |
JP (1) | JPS5589225A (sv) |
AT (1) | AT369654B (sv) |
BE (1) | BE880830A (sv) |
CA (1) | CA1133395A (sv) |
CH (1) | CH643739A5 (sv) |
DE (1) | DE2856333C2 (sv) |
FR (1) | FR2445146A1 (sv) |
GB (1) | GB2039738B (sv) |
IT (1) | IT1164550B (sv) |
NL (1) | NL7909244A (sv) |
SE (1) | SE448603B (sv) |
ZA (1) | ZA797008B (sv) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2914788A1 (de) * | 1979-04-11 | 1980-10-16 | Nattermann A & Cie | Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung |
DE2914789A1 (de) * | 1979-04-11 | 1980-10-16 | Nattermann A & Cie | Injizierbare arzneimittel mit entzuendungshemmender wirkung |
DE2952115C2 (de) * | 1979-12-22 | 1982-05-06 | A. Nattermann & Cie GmbH, 5000 Köln | Rosmarinsäure-Phospholipid-Komplex |
US4374082A (en) * | 1981-08-18 | 1983-02-15 | Richard Hochschild | Method for making a pharmaceutical and/or nutritional dosage form |
EP0092121B1 (en) * | 1982-04-12 | 1987-12-16 | Board Of Regents, The University Of Texas System | Methods and compositions for treating gastro-intestinal ulcer diesease |
GB2119244A (en) * | 1982-04-30 | 1983-11-16 | Alza Corp | Potassium replacement therapy |
US4666893A (en) * | 1983-02-15 | 1987-05-19 | St. Thomas Institute | Methods of inducing resistance to bacterial and viral infections |
CA1237670A (en) * | 1983-05-26 | 1988-06-07 | Andrew S. Janoff | Drug preparations of reduced toxicity |
US5059591B1 (en) * | 1983-05-26 | 2000-04-25 | Liposome Co Inc | Drug preparations of reduced toxicity |
DE3346525C2 (de) * | 1983-12-22 | 1987-03-19 | A. Nattermann & Cie GmbH, 5000 Köln | Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-glycero-3-phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich |
DE3346526C2 (de) * | 1983-12-22 | 1986-12-11 | A. Nattermann & Cie GmbH, 5000 Köln | Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen |
PT78628B (en) * | 1984-05-02 | 1986-06-18 | Liposome Co Inc | Pharmaceutical composition with reduced toxicity |
IL79114A (en) * | 1985-08-07 | 1990-09-17 | Allergan Pharma | Method and composition for making liposomes |
US5283067A (en) * | 1987-01-30 | 1994-02-01 | Ciba-Geigy Corporation | Parenteral suspensions |
US5032585A (en) * | 1987-02-17 | 1991-07-16 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy |
US5260284A (en) * | 1987-02-17 | 1993-11-09 | Board Of Regents, The University Of Texas System | Methods employing unique mixtures of polar and neutral lipids and sterol for lung surfactant replacement therapy |
US5043329A (en) * | 1987-02-17 | 1991-08-27 | Board Of Regents, University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
US4950656A (en) * | 1987-02-17 | 1990-08-21 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
US4918063A (en) * | 1987-02-17 | 1990-04-17 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
US5030452A (en) * | 1989-01-12 | 1991-07-09 | Pfizer Inc. | Dispensing devices powered by lyotropic liquid crystals |
US5091187A (en) * | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
US5091188A (en) * | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
US5763422A (en) * | 1995-01-27 | 1998-06-09 | Board Of Regents, The University Of Texas System | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein |
US5955451A (en) * | 1995-05-12 | 1999-09-21 | The University Of Texas System Board Of Regents | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein |
ATE386506T1 (de) * | 1995-10-17 | 2008-03-15 | Jagotec Ag | Verabreichung unlöslicher arzneistoffe |
AUPN766496A0 (en) * | 1996-01-22 | 1996-02-15 | University Of New England, The | Method and composition for the potentiation of anti-inflammatory drugs |
US7255877B2 (en) * | 1996-08-22 | 2007-08-14 | Jagotec Ag | Fenofibrate microparticles |
US6465016B2 (en) | 1996-08-22 | 2002-10-15 | Research Triangle Pharmaceuticals | Cyclosporiine particles |
WO1999040906A2 (en) * | 1998-02-11 | 1999-08-19 | Research Triangle Pharmaceuticals | Method and composition for treatment of inflammatory conditions |
US6979456B1 (en) | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
ATE259220T1 (de) | 1998-05-29 | 2004-02-15 | Skyepharma Canada Inc | Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben |
CN1221249C (zh) | 1998-08-19 | 2005-10-05 | 斯凯伊药品加拿大公司 | 普鲁泊福的可注射水分散体 |
ID29270A (id) | 1998-11-20 | 2001-08-16 | Rtp Pharma Inc | Partikel-partikel mikro yang distabilkan oleh fosfolipid yang dapat menyebar |
EP1214059B1 (en) * | 1999-09-21 | 2005-05-25 | Skyepharma Canada Inc. | Surface modified particulate compositions of biologically active substances |
CA2407027C (en) | 2000-04-20 | 2011-02-15 | Rtp Pharma Inc. | Improved water-insoluble drug particle process |
CA2420597C (en) | 2000-08-31 | 2011-05-17 | Rtp Pharma Inc. | Milled particles |
US8586094B2 (en) * | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets |
TWI354568B (en) * | 2000-09-20 | 2011-12-21 | Jagotec Ag | Insoluble drug particle compositions with improved |
US20040077604A1 (en) * | 2001-12-19 | 2004-04-22 | Lenard Lichtenberger | Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity |
US20100173876A1 (en) * | 2000-12-19 | 2010-07-08 | The Board Of Regents Of The University Of Texas System | Oil-based nsaid compositions and methods for making and using same |
ATE357216T1 (de) * | 2001-02-22 | 2007-04-15 | Jagotec Ag | Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen |
CA2850187C (en) | 2011-09-29 | 2021-12-07 | Plx Pharma Inc. | Ph dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
WO2016185816A1 (ja) * | 2015-05-18 | 2016-11-24 | 不二製油グループ本社株式会社 | IL-1β産生抑制作用を有する食品添加用組成物 |
MX2022011743A (es) | 2020-03-26 | 2022-12-08 | Plx Opco Inc | Portadores farmaceuticos con capacidad de reconstitucion dependiente del ph y metodos para elaborar y usar los mismos. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL32337C (sv) * | ||||
IT1044768B (it) * | 1969-04-03 | 1980-04-21 | Italeapmaco Spa | Supposte contenenti un principio attivo ascorbato di aminofemazione liofilizzato e processo per la loro preparazione |
-
1978
- 1978-12-27 DE DE2856333A patent/DE2856333C2/de not_active Expired
-
1979
- 1979-12-17 US US06/104,449 patent/US4332795A/en not_active Expired - Lifetime
- 1979-12-17 CH CH1114579A patent/CH643739A5/de not_active IP Right Cessation
- 1979-12-17 SE SE7910371A patent/SE448603B/sv not_active IP Right Cessation
- 1979-12-18 JP JP16368279A patent/JPS5589225A/ja active Granted
- 1979-12-19 FR FR7931087A patent/FR2445146A1/fr active Granted
- 1979-12-19 CA CA342,252A patent/CA1133395A/en not_active Expired
- 1979-12-20 GB GB7943966A patent/GB2039738B/en not_active Expired
- 1979-12-21 AT AT0808379A patent/AT369654B/de not_active IP Right Cessation
- 1979-12-21 IT IT28358/79A patent/IT1164550B/it active
- 1979-12-21 NL NL7909244A patent/NL7909244A/nl not_active Application Discontinuation
- 1979-12-21 BE BE198724A patent/BE880830A/fr unknown
- 1979-12-27 ZA ZA00797008A patent/ZA797008B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB2039738B (en) | 1983-04-13 |
NL7909244A (nl) | 1980-07-01 |
IT1164550B (it) | 1987-04-15 |
JPS6320209B2 (sv) | 1988-04-26 |
CH643739A5 (de) | 1984-06-29 |
CA1133395A (en) | 1982-10-12 |
DE2856333A1 (de) | 1980-08-21 |
US4332795A (en) | 1982-06-01 |
FR2445146A1 (fr) | 1980-07-25 |
ATA808379A (de) | 1982-06-15 |
AT369654B (de) | 1983-01-25 |
JPS5589225A (en) | 1980-07-05 |
BE880830A (fr) | 1980-04-16 |
ZA797008B (en) | 1980-12-31 |
FR2445146B1 (sv) | 1983-09-02 |
DE2856333C2 (de) | 1983-09-22 |
GB2039738A (en) | 1980-08-20 |
SE448603B (sv) | 1987-03-09 |
IT7928358A0 (it) | 1979-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7910371L (sv) | Oralt intagbart lekemedel med inflammationshemmande verkan | |
ES2102367T3 (es) | Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion. | |
AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
IT8220073A0 (it) | Composto ad attivita' analgesica, antiinfiammatoria e mucoregolatrice procedimento per la sua preparazione e relative composizioni farmaceutiche | |
DE3475691D1 (en) | Injectable solution for the treatment of inflammations | |
ES557836A0 (es) | Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables. | |
SE8304003L (sv) | Medicinsk komposition innehallande pirprofen | |
PT81885B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo uma combinacao sinergetica de flupirtina e antiflogisticos nao esteroides | |
GB9212450D0 (en) | New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them | |
DE3860201D1 (de) | Entzuendungshemmende agentien. | |
ES2054715T3 (es) | Nuevos derivados de naftaleno y productos farmaceuticos antialergicos y antiinflamatorios. | |
ES506018A0 (es) | Un procedimiento para la preparacion de una composicion far-maceutica a base de esteroides anti-inflamatorios | |
ES2054650T3 (es) | Fenilacetonitrilos basicamente substituidos, su obtencion y medicamentos que los contienen. | |
MX9304503A (es) | Compuestos antiinflamatorios. | |
IT1151953B (it) | Composizione farmaceutica per la cura di affezioni della cavita' orale | |
PT81933B (pt) | Processo para a preparacao de composicoes aperfeicoadas anti-inflamatorias contendo piroxicamo e inositol | |
ES490453A0 (es) | Un procedimiento para la preparacion de una composicion far-maceutica de quinazolinonas analgesicas | |
ES2043943T3 (es) | Procedimiento para la preparacion de compuestos con actividad analgesica central. | |
ES2077473T3 (es) | Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
JPS5583758A (en) | Novel 3*44diazaabicyclo*4*1*0*heptenee*2**onee *5**its manufacture and medicine containing it | |
ATE89163T1 (de) | Topisch anzuwendende diclofenac enthaltende arzneizubereitungen. | |
MX7715E (es) | Procedimiento para la preparacion de una composicion farmaceutica a base de microgranulos que contiene sulpirida | |
BR9302809A (pt) | Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral | |
DK400887A (da) | Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel | |
DK374584D0 (da) | Analgetikum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 7910371-9 Effective date: 19930709 Format of ref document f/p: F |